Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO)

Clinical Endocrinology

Volumn 71, Issue 1, 2009, Pages 11-17

  Timmers, Henri J L M ^b,c   Eisenhofer, Graeme ^b,d   Carrasquillo, Jorge A ^e   Chen, Clara C ^e   Whatley, Millie ^e   Ling, Alexander ^f   Adams, Karen T ^b   Pacak, Karel ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e Nuclear Medicine Department   (France)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; 6 FLUORODOPAMINE F 18; CATECHOLAMINE; METADRENALIN; 6 FLUORODOPAMINE; 6-FLUORODOPAMINE; DIAGNOSTIC AGENT; DOPAMINE; DRUG DERIVATIVE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CATECHOLAMINE BLOOD LEVEL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHOLE BODY SCINTISCANNING; CANCER STAGING; CHEMISTRY; CLINICAL TRIAL; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADULT; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY;

EID: 66949156033     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03496.x     Document Type: Article

References (25)

1. DeLellis, R.A., Lloyd, R.V., Heitz, P.U. et al. (2004) Oxford University Press, Oxford, UK.
2. Lenders, J.W., Pacak, K., Walther, M.M. et al. (2002) Biochemical diagnosis of phaeochromocytoma: which test is best? Journal of the American Medical Association, 287, 1427 1434. (Pubitemid 34250506)
3. Eisenhofer, G. (2001) The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacological Therapy, 91, 35 62. (Pubitemid 33055773)
4. Timmers, H.J., Kozupa, A., Chen, C.C. et al. (2007) Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated phaeochromocytoma and paraganglioma. Journal of Clinical Oncology, 25, 2262 2269. (Pubitemid 46954653)
5. Van Der Horst-Schrivers, A.N., Jager, P.L., Boezen, H.M. et al. (2006) Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas - experience and meta-analysis. Anticancer Research, 26, 1599 1604.
6. 123I] metaiodobenzylguanidine and [(111) In]octreotide uptake in benign and malignant phaeochromocytomas. Journal of Clinical Endocrinology and Metabolism, 86, 685 693. (Pubitemid 32207482)
7. 18F]-fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of phaeochromocytoma. Hypertension, 38, 6 8. (Pubitemid 34224762)
8. Ilias, I., Shulkin, B. Pacak, K. (2005) New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas. Trends in Endocrinology and Metabolism, 16, 66 72. (Pubitemid 40270852)
9. Shulkin, B.L., Wieland, D.M., Schwaiger, M. et al. (1992) PET scanning with hydroxyephedrine: an approach to the localization of phaeochromocytoma. Journal of Nuclear Medicine, 33, 1125 1131.
10. 131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic phaeochromocytoma. Journal of Clinical Endocrinology and Metabolism, 88, 4083 4087. (Pubitemid 37153702)
11. 123I]- metaiodobenzylguanidine-negative metastatic phaeochromocytoma sites. Nuclear Medicine Communications, 27, 31 36. (Pubitemid 44391837)
12. 18F DOPA whole body PET - initial results. Radiology, 222, 507 512. (Pubitemid 34106126)
13. Brink, I., Schaefer, O., Walz, M. et al. (2006) Fluorine-18 DOPA PET imaging of paraganglioma syndrome. Clinical Nuclear Medicine, 31, 39 41. (Pubitemid 43011938)
14. 18F-Fluoro-L-DOPA in PET of phaeochromocytoma and extraadrenal abdominal paraganglioma. Journal of Nuclear Medicine, 48, 1599 1606. (Pubitemid 47572706)
15. Lenders, J.W., Eisenhofer, G., Armando, I. et al. (1993) Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clinical Chemistry, 39, 97 103.
16. Eisenhofer, G., Goldstein, D.S., Stull, R. et al. (1986) Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clinical Chemistry, 32, 2030 2033.
17. Eisenhofer, G., Goldstein, D.S., Walther, M.M. et al. 2003) Biochemical diagnosis of phaeochromocytoma: how to distinguish true- from false-positive test results. Journal of Clinical Endocrinology and Metabolism, 88, 2656 2666. (Pubitemid 36724439)
18. Pacak, K. (2007) Preoperative management of the phaeochromocytoma patient. Journal of Clinical Endocrinology and Metabolism, 92, 4069 4079.
19. 18F]-6-fluorodopamine. Journal of Nuclear Medicine, 32, 102 110.
20. Dorfman, R.E., Alpern, M.B., Gross, B.H. et al. (1991) Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology, 180, 319 322.
21. Glazer, G.M., Gross, B.H., Quint, L.E. et al. (1985) Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. American Journal of Roentgenology, 144, 261 265. (Pubitemid 15168325)
22. Mancuso, A.A., Harnsberger, H.R., Muraki, A.S. et al. (1983) Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and applications in staging head and neck cancer. Part I: normal anatomy. Radiology, 148, 709 714.
23. Lynn, M.D., Shapiro, B., Sisson, J.C. et al. (1985) Phaeochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy. Radiology, 155, 789 792. (Pubitemid 15042791)
24. Linnoila, R.I., Keiser, H.R., Steinberg, S.M. et al. (1990) Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Human Pathology, 21, 1168 1180. (Pubitemid 20382001)
25. 18F- fluorodopamine PET. Journal of Nuclear Medicine, 48, 1940 1944. (Pubitemid 350232301)